June 18, 2019
Sanofi K.K., the Japan arm of Sanofi S.A., said on June 17 that results from a database study on patients with cold agglutinin disease (CAD) in Japan demonstrated that CAD patients have a higher risk of thromboembolism (TE), compared with...read more